NanoViricides Inc (NNVC)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $31.41M
Last updated: Nov 17, 2026 at 11:05 AM ET
NanoViricides Inc (NNVC) Competitors
The companies most similar to NanoViricides are Mink Therapeutics (INKT), NextCure (NXTC) and INmune Bio (INMB). By market cap, NanoViricides ranks 9th of the 13 companies on this page; Mink Therapeutics (INKT) is the largest at $47.95M.
Peer Comparison
NNVC's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| NanoViricides (NNVC) | $31.41M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Mink Therapeutics Inc (INKT) | $47.95M | N/A | 236.3x | 0.0% | N/A | 0.0% | 0.00% |
| NextCure Inc (NXTC) | $29.31M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| INmune Bio Inc (INMB) | $32.51M | N/A | N/A | 0.0% | N/A | 257.1% | 0.00% |
| Veru Inc (VERU) | $35.64M | N/A | N/A | 0.0% | N/A | 18.3% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| ProMIS Neurosciences Inc. (PMN) | $29.60M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Vyne Therapeutics Inc (VYNE) | $19.07M | N/A | N/A | 0.0% | N/A | -57.4% | 0.00% |
| Cocrystal Pharma Inc (COCP) | $18.88M | N/A | 39.2x | 0.0% | N/A | 26.9% | 0.00% |
| Serina Therapeutics Inc (SER) | $36.93M | N/A | 288.7x | 0.0% | -109.4% | 154.9% | 0.00% |
| ImageneBio, Inc. (IMA) | $43.22M | N/A | 68.5x | 0.0% | N/A | 0.0% | 0.00% |
| Biomea Fusion Inc (BMEA) | $42.31M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Quince Therapeutics, Inc. (QNCX) | $32.27M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $34.07M | N/A | 152.4x | 0.0% | -109.4% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to NanoViricides, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Mink Therapeutics Inc (INKT) | MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic... | INKT competitors |
| NextCure Inc (NXTC) | NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other... | NXTC competitors |
| INmune Bio Inc (INMB) | INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease... | INMB competitors |
| Veru Inc (VERU) | Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. | VERU competitors |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human... | TELO competitors |
| ProMIS Neurosciences Inc. (PMN) | ProMIS Neurosciences Inc. is a pioneering biotechnology company focused on the development of innovative therapeutic solutions for neurodegenerative diseases... | PMN competitors |
| Vyne Therapeutics Inc (VYNE) | VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapies for dermatology. | |
| Cocrystal Pharma Inc (COCP) | Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic... | COCP competitors |
| Serina Therapeutics Inc (SER) | Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology... | SER competitors |
| ImageneBio, Inc. (IMA) | ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. | IMA competitors |
| Biomea Fusion Inc (BMEA) | Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat... | BMEA competitors |
| Quince Therapeutics, Inc. (QNCX) | Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases. |
Frequently Asked Questions About NNVC
Who are NanoViricides' main competitors?
The companies most similar to NanoViricides include Mink Therapeutics (INKT), NextCure (NXTC), INmune Bio (INMB), Veru (VERU) and Telomir Pharmaceuticals, Inc. Common Stock (TELO), listed from the closest match.
Who is NanoViricides' biggest competitor?
Mink Therapeutics (INKT) is both the largest of the similar companies at $47.95M and the closest match by business profile, size, sector and industry.
How does NNVC stock compare with its competitors?
NNVC's net margin is 0.0% against a peer median of 0.0%.
Which of NanoViricides' competitors pays a higher dividend?
NanoViricides pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is NanoViricides bigger than its competitors?
No. NanoViricides is 9th by market cap among the 13 companies on this page; the largest is Mink Therapeutics (INKT) at $47.95M.
NNVC pages: Overview, Earnings, Forecast, Financials, Competitors